139 related articles for article (PubMed ID: 33237537)
1. Isolation and Phenotyping of Splenic Myeloid-Derived Suppressor Cells in Murine Cancer Models.
Sanseviero E; Kim R; Gabrilovich DI
Methods Mol Biol; 2021; 2236():19-28. PubMed ID: 33237537
[TBL] [Abstract][Full Text] [Related]
2. Immunophenotyping of Circulating Myeloid-Derived Suppressor Cells (MDSC) in the Peripheral Blood of Cancer Patients.
Bruderek K; Schirrmann R; Brandau S
Methods Mol Biol; 2021; 2236():1-7. PubMed ID: 33237535
[TBL] [Abstract][Full Text] [Related]
3. Phenotypical Characterization and Isolation of Tumor-Derived Mouse Myeloid-Derived Suppressor Cells.
Barouni RM; Musiu C; Bronte V; Ugel S; Canè S
Methods Mol Biol; 2021; 2236():29-42. PubMed ID: 33237538
[TBL] [Abstract][Full Text] [Related]
4. CCL9/CCR1 induces myeloid‑derived suppressor cell recruitment to the spleen in a murine H22 orthotopic hepatoma model.
Li B; Zhang S; Huang N; Chen H; Wang P; Yang J; Li Z
Oncol Rep; 2019 Jan; 41(1):608-618. PubMed ID: 30365155
[TBL] [Abstract][Full Text] [Related]
5. Depletion and Maturation of Myeloid-Derived Suppressor Cells in Murine Cancer Models.
Groth C; Weber R; Utikal J; Umansky V
Methods Mol Biol; 2021; 2236():67-75. PubMed ID: 33237541
[TBL] [Abstract][Full Text] [Related]
6. Preparation of myeloid derived suppressor cells (MDSC) from naive and pancreatic tumor-bearing mice using flow cytometry and automated magnetic activated cell sorting (AutoMACS).
Nelson N; Szekeres K; Cooper D; Ghansah T
J Vis Exp; 2012 Jun; (64):e3875. PubMed ID: 22733203
[TBL] [Abstract][Full Text] [Related]
7. Identification of a Novel Subset of Myeloid-Derived Suppressor Cells During Chronic Staphylococcal Infection That Resembles Immature Eosinophils.
Goldmann O; Beineke A; Medina E
J Infect Dis; 2017 Dec; 216(11):1444-1451. PubMed ID: 29029332
[TBL] [Abstract][Full Text] [Related]
8. Circulating Myeloid Derived Suppressor Cells (MDSC) That Accumulate in Premalignancy Share Phenotypic and Functional Characteristics With MDSC in Cancer.
Ma P; Beatty PL; McKolanis J; Brand R; Schoen RE; Finn OJ
Front Immunol; 2019; 10():1401. PubMed ID: 31275327
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients.
Jordan KR; Kapoor P; Spongberg E; Tobin RP; Gao D; Borges VF; McCarter MD
Cancer Immunol Immunother; 2017 Apr; 66(4):503-513. PubMed ID: 28108766
[TBL] [Abstract][Full Text] [Related]
10. Isolation of Human Circulating Myeloid-Derived Suppressor Cells and Analysis of Their Immunosuppressive Activity.
Bruderek K; Schirrmann R; Brandau S
Methods Mol Biol; 2021; 2236():43-56. PubMed ID: 33237539
[TBL] [Abstract][Full Text] [Related]
11. Dexmedetomidine expands monocytic myeloid-derived suppressor cells and promotes tumour metastasis after lung cancer surgery.
Su X; Fan Y; Yang L; Huang J; Qiao F; Fang Y; Wang J
J Transl Med; 2018 Dec; 16(1):347. PubMed ID: 30537999
[TBL] [Abstract][Full Text] [Related]
12. Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates.
Cassetta L; Baekkevold ES; Brandau S; Bujko A; Cassatella MA; Dorhoi A; Krieg C; Lin A; Loré K; Marini O; Pollard JW; Roussel M; Scapini P; Umansky V; Adema GJ
Cancer Immunol Immunother; 2019 Apr; 68(4):687-697. PubMed ID: 30684003
[TBL] [Abstract][Full Text] [Related]
13. Splenic Hematopoietic and Stromal Cells in Cancer Progression.
Steenbrugge J; De Jaeghere EA; Meyer E; Denys H; De Wever O
Cancer Res; 2021 Jan; 81(1):27-34. PubMed ID: 32998999
[TBL] [Abstract][Full Text] [Related]
14. Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreatic cancer model.
Metzger P; Kirchleitner SV; Boehmer DFR; Hörth C; Eisele A; Ormanns S; Gunzer M; Lech M; Lauber K; Endres S; Duewell P; Schnurr M; König LM
Cancer Immunol Immunother; 2020 Oct; 69(10):2101-2112. PubMed ID: 32448983
[TBL] [Abstract][Full Text] [Related]
15. Human splenic polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC) are strategically located immune regulatory cells in cancer.
Tavukcuoglu E; Horzum U; Yanik H; Uner A; Yoyen-Ermis D; Nural SK; Aydin B; Sokmensuer C; Karakoc D; Yilmaz KB; Hamaloglu E; Esendagli G
Eur J Immunol; 2020 Dec; 50(12):2067-2074. PubMed ID: 32691408
[TBL] [Abstract][Full Text] [Related]
16. Measuring Suppressive Activity and Autophagy in Myeloid-Derived Suppressor Cells.
Papaioannou AS; Boumpas A; Papadopoulou M; Hatzioannou A; Alissafi T; Verginis P
Methods Mol Biol; 2021; 2236():85-98. PubMed ID: 33237543
[TBL] [Abstract][Full Text] [Related]
17. High-Dimensional Analysis of Circulating and Tissue-Derived Myeloid-Derived Suppressor Cells from Patients with Glioblastoma.
Alban TJ; Bayik D; Alvarado AG; Kornblum HI; Lathia JD
Methods Mol Biol; 2021; 2236():157-175. PubMed ID: 33237547
[TBL] [Abstract][Full Text] [Related]
18. Plasticity of myeloid-derived suppressor cells in cancer.
Tcyganov E; Mastio J; Chen E; Gabrilovich DI
Curr Opin Immunol; 2018 Apr; 51():76-82. PubMed ID: 29547768
[TBL] [Abstract][Full Text] [Related]
19. Cyclophosphamide-induced myeloid-derived suppressor cell population is immunosuppressive but not identical to myeloid-derived suppressor cells induced by growing TC-1 tumors.
Mikyšková R; Indrová M; Polláková V; Bieblová J; Símová J; Reiniš M
J Immunother; 2012 Jun; 35(5):374-84. PubMed ID: 22576342
[TBL] [Abstract][Full Text] [Related]
20. Isolation of myeloid-derived suppressor cells (MDSC) from endometriotic mice model and their immunomodulatory functions.
Song Y; Liu Y; Xu Q; Leung KT; Chan LKY; Chung JPW; Wang CC; Chen X; Zhang T; Man GCW
Methods Cell Biol; 2024; 184():33-57. PubMed ID: 38555157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
